Optimisation of SARS-CoV-2 peptide stimulation and measurement of cytokine output by intracellular flow cytometry and bio-plex analysis

Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations

(2023) Pawan Kumar Raghav et al.   Scientific Reports

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

(2022) Chansavath Phetsouphanh et al.   NATURE IMMUNOLOGY

Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients

(2022) Andrew H. Karaba et al.   TRANSPLANTATION

Human autoantibodies underlying infectious diseases

(2022) Anne Puel et al.   JOURNAL OF EXPERIMENTAL MEDICINE

COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes

(2022) Banafsheh Bigdelou et al.   Frontiers in Immunology

Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review

(2021) Abraham Edgar Gracia-Ramos et al.   RHEUMATOLOGY INTERNATIONAL

Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients

(2021) Moritz Anft et al.   JOURNAL OF NEPHROLOGY

Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients

(2021) Cristina Bergamaschi et al.   Cell Reports

SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees

(2021) Daryl Geers et al.   Science Immunology

Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

(2020) Hongzhou Lu et al.   JOURNAL OF MEDICAL VIROLOGY

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

(2020) Roujian Lu et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

(2020) Zhe Xu et al.   Lancet Respiratory Medicine

Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19

(2020) Ahmet Kursat Azkur et al.   ALLERGY

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

(2020) Alba Grifoni et al.   CELL

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

(2020) Vanessa Monteil et al.   CELL

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

(2020) Evangelos J. Giamarellos-Bourboulis et al.   Cell Host & Microbe

Camostat mesilate therapy for COVID-19

(2020) Yoshiharu Uno   Internal and Emergency Medicine

Clinical and immunological features of severe and moderate coronavirus disease 2019

(2020) Guang Chen et al.   JOURNAL OF CLINICAL INVESTIGATION

Baricitinib for COVID-19: a suitable treatment?

(2020) Ennio G Favalli et al.   LANCET INFECTIOUS DISEASES

Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes

(2020) Mario Adán Moreno-Eutimio et al.   MICROBES AND INFECTION

Cytokines and costimulation in acute graft-versus-host disease

(2020) Geoffrey R. Hill et al.   BLOOD

Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology

(2020) Eduardo Mantovani Cardoso et al.   CLINICAL RHEUMATOLOGY

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

(2020) Nina Le Bert et al.   NATURE

Candidate drugs against SARS-CoV-2 and COVID-19

(2020) Dwight L. McKee et al.   PHARMACOLOGICAL RESEARCH

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

(2020) Takuya Sekine et al.   CELL

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

(2020) Yanchun Peng et al.   NATURE IMMUNOLOGY

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

(2020) Paul Bastard et al.   SCIENCE

Multiple sclerosis following SARS-CoV-2 infection

(2020) M. Palao et al.   Multiple Sclerosis and Related Disorders

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

(2020) Lauren B. Rodda et al.   CELL

Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection

(2016) Oi-Wing Ng et al.   VACCINE

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

(2014) Shannon L. Maude et al.   NEW ENGLAND JOURNAL OF MEDICINE

Brefeldin A Induces Apoptosis by Activating the Mitochondrial and Death Receptor Pathways and Inhibits Focal Adhesion Kinase-Mediated Cell Invasion

(2013) Seon A. Lee et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Therapeutic blockade of TNF in patients with SLE—Promising or crazy?

(2011) Martin Aringer et al.   AUTOIMMUNITY REVIEWS

Rhesus Theta-Defensin Prevents Death in a Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Pulmonary Disease

(2009) C. L. Wohlford-Lenane et al.   JOURNAL OF VIROLOGY

Efficacy and safety of infliximab in active SLE: a pilot study

(2009) SS Uppal et al.   LUPUS

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis

(2009) Peter C. Taylor et al.   Nature Reviews Rheumatology

Inducible Bronchus-Associated Lymphoid Tissue Elicited by a Protein Cage Nanoparticle Enhances Protection in Mice against Diverse Respiratory Viruses

(2009) James A. Wiley et al.   PLoS One

Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome

(2008) Yongmin Tang et al.   BRITISH JOURNAL OF HAEMATOLOGY